Abstract | INTRODUCTION: The exhaustion and poor homing of activated lymphocytes are critical obstacles in adoptive cell immunotherapy for solid tumors. In order to effectively deliver immune cells into tumors, we encapsulated interferon-α2b (IFN-α2b) into macroporous hydrogels as an enhancement factor and utilized low-dose irradiation (LDI) as a tumoral attractor of T cells. METHODS:
Hydroxypropyl cellulose hydrogels were prepared by irradiation techniques, and the cross-sectional microstructure was characterized by scanning electron microscopy. The synergistic antitumor mechanism of combination of IFN-α2b and CIK cells was evaluated by detecting the expression of activation marker CD69 on CIK cell surface and IFN-γ production by CIK cells. The in vivo antitumor activity of IFN-α2b-incorporated hydroxypropyl cellulose hydrogels combined with CIK and radiation was evaluated in an MKN-45 xenografted nude mice model. RESULTS: The bioactivity of IFN-α2b was well maintained in ultraviolet-reactive, rapidly cross-linkable hydroxypropyl cellulose hydrogels. In vitro studies demonstrated IFN-α2b-activated T cells, as evidenced by upregulating early activation marker CD69 and secretion inflammatory cytokine IFN-γ. In vivo real-time image showed our hydrogels kept a higher amount of drug delivery at the tumor site for a long time compared with free drug injection. Low-dose irradiation promoted T cell accumulation and infiltration in subcutaneous tumors. Combination of IFN-α2b-loaded hydrogels (Gel-IFN) with T cells and LDI exhibited higher efficacy to eradicate human gastric cancer xenograted tumors with less proliferating cells and more necrotic regions compared with IFN-α2b or T cells alone. DISCUSSION: HPC hydrogels kept the activity of IFN-α2b and stably release of IFN-α2b to stimulate T cells for a long time. At the same time, low-dose radiation recruits T cells into tumors. This innovative integration mode of IFN-α2b-loaded hydrogels and radiotherapy offers a potent strategy to improve the therapeutic outcome of T cell therapy.
|
Authors | Qin Liu, Dinghu Zhang, Hanqing Qian, Yanhong Chu, Yan Yang, Jie Shao, Qiuping Xu, Baorui Liu |
Journal | International journal of nanomedicine
(Int J Nanomedicine)
Vol. 15
Pg. 3669-3680
( 2020)
ISSN: 1178-2013 [Electronic] New Zealand |
PMID | 32547021
(Publication Type: Journal Article)
|
Copyright | © 2020 Liu et al. |
Chemical References |
- Antineoplastic Agents
- Cross-Linking Reagents
- Hydrogels
- Interferon alpha-2
- Interferon-alpha
- Interferon-alpha2b
- Cellulose
- hydroxypropylcellulose
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cellulose
(analogs & derivatives, chemistry)
- Cross-Linking Reagents
(chemistry)
- Dose-Response Relationship, Radiation
- Electrons
- Humans
- Hydrogels
(chemistry)
- Interferon alpha-2
- Interferon-alpha
(pharmacology, therapeutic use)
- Light
- Male
- Mice, Inbred BALB C
- Mice, Nude
- Stomach Neoplasms
(drug therapy, radiotherapy)
- T-Lymphocytes
(drug effects, immunology)
- Xenograft Model Antitumor Assays
|